Bausch starts study for dry eye disease linked with Meibomian Gland Dysfunction
Bausch Health Companies Inc and its global eye health business Bausch + Lomb have announced that the second of two Phase 3 studies evaluating...
Covid breakthrough: Baricitinib plus remdesivir show promising results in treating Corona infection
Covid treatment is no more a dream. In a relif to those who are waiting for Covid-19 medicine, it has emerged that combination of...
Daewoong, Sygnature Discovery eyes autoimmune disease research
South Korea-based Daewoong Pharmaceutical has entered a research collaboration with Sygnature Discovery to expand its global open innovation for novel drug development.
Daewoong Pharmaceutical enters...
